Allergan's Westport Botox plant makes $1.5bn in profits Westport's status as the global production capital of Botox was further enhanced last year as world wide sales of the treatment from a local manufacturing … Business • 29 Nov
Botox boom boosts Allergan's Westport plant A global surge in the sales of Botox produced at Allergan's Westport plant helped the business record pre-tax profits of $1.327bn (€1.245bn) in 2021. Business • 17 Feb
AbbVie's 'precautionary' court action against Revenue Pharmaceutical giant AbbVie has brought a "precautionary" High Court action against Revenue arising from a €587m tax bill served on it after it acquired Allergen. Business • 19 Jan 21
AbbVie reports loss as Covid-19 hits Botox sales Drugmaker AbbVie has today reported a loss in the second quarter, as comparable sales from wrinkle treatment Botox, acquired as part of its $63 billion … Business • 31 Jul 20
Allergan opens new €160m biologics plant in Westport Allergan, the maker of Botox, is opening a new €160m biologics facility at its campus in Westport in Co Mayo. Business • 28 Jan 20
Nestle buys Allergan's Zenpep in medical nutrition deal Swiss food giant Nestle has bulked up its medical nutrition business by buying Allergan's Zenpep, a product for people whose pancreases do not provide enough … Business • 27 Jan 20
EU conditionally approves Allergan takeover by Abbvie The European Commission has approved US drugmaker AbbVie's planned $63 billion acquisition of Dublin headquartered Botox-maker Allergan, subject to conditions. Business • 10 Jan 20
Allergan's migraine treatment wins US FDA approval The US Food and Drug Administration has approved Allergan drug for relieving migraine headaches after their onset. Business • 24 Dec 19
Irish profits sagged at Botox maker Allergan last year Pre-tax profits at Co Mayo-based Botox producer, Allergan Pharmaceuticals Ireland last year declined by 17% to $187m (€168.69m) Business • 04 Dec 19
Allergan shareholders give AbbVie takeover green light Shareholders at Dublin headquartered Botox-maker Allergan have strongly backed its $63bn takeover by US pharmaceutical company AbbVie. Business • 14 Oct 19
AbbVie to buy Botox-maker Allergan in $63 billion deal AbbVie said today it would buy Botox-maker Allergan in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics … Business • 25 Jun 19
Allergan raises 2019 forecasts as Botox boosts results Allergan today raised its profit and revenue forecasts for the year as it beat expectations for quarterly profit, fueled by higher sales of its blockbuster … Business • 07 May 19
163 new Connacht jobs in wedding, botox companies A wedding planning company is to create 100 jobs in Galway, while a further 63 jobs have been announced for Mayo plant Allergan. Connacht • 29 Apr 19
Allergan tops profit estimates on Botox sales Allergan today topped analysts' estimates for quarterly profit and raised its forecast for annual earnings, led by stronger demand for medical aesthetic products including Botox. Business • 26 Jul 18
Botox-maker Allergan quarterly revenue rises 2.8% Botox maker Allergan today reported a better-than-expected quarterly profit and raised its full-year forecast for adjusted net income. Business • 30 Apr 18
Japan's Takeda nudges up Shire offer to £47 a share Japan's Takeda Pharmaceutical has increased its offer for Shire to $47 a share after its three previous bids - the last at £46.50 - were … Business • 20 Apr 18
Allergan posts quarterly profit ahead of estimates Botox-maker Allergan has reported adjusted profit that beat analysts' estimates, and raised its 2017 forecast to include its $2.48 billion acquisition of Zeltiq Aesthetics. Business • 09 May 17
Allergan to invest €42m in its Irish operations Botox maker Allergan has confirmed an additional investment of €42m in its Irish operations for this year. Business • 01 Mar 17
Allergan to buy Zeltiq Aesthetics for $2.5 billion Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion, adding muscle to its line-up of products used to fight fat … Business • 13 Feb 17
Teva to sell Allergan's generics unit in Ireland Teva Pharmaceutical Industries is to sell Allergan's generics business in the UK and Ireland to India's Intas Pharmaceuticals for £603m. Business • 06 Oct 16
Pfizer abandons plan to split into two companies US drugmaker Pfizer, which has been considering a split into two companies for more than two years, said it will not do so because the … Business • 26 Sep 16
Allergan reports 48% rise in quarterly revenues Allergan, whose $160 billion merger with Pfizer fell apart last month, today reported a better than expected quarterly profit today, led by strong sales of … Business • 10 May 16
Pfizer's Q1 revenue beats on Hospira acquisition US drugmaker Pfizer today reported first-quarter revenue that blew past analysts' average estimate, boosted by sales of its new treatments for cancer and its Hospira … Business • 03 May 16
Allergan shares fall on fears of deal collapse Shares in Allergan opened over 15% lower today, after the US Treasury Department proposed new tax regulations that analysts said could kill its $160 billion … Business • 05 Apr 16
Allergan reports higher than expected Q4 revenue Allergan has reported better than expected quarterly revenues, helped by strong performance in its US brands segment. Business • 22 Feb 16
